NCT03998839View on ClinicalTrials.gov

TIPTOP Sulfadoxine-pyrimethamine (SP) Drug Resistance Study

CompletedOBSERVATIONAL
Enrollment

7,200

Participants

Timeline

Start Date

March 5, 2018

Primary Completion Date

November 30, 2021

Study Completion Date

November 30, 2021

Conditions
Malaria in Pregnancy
Interventions
OTHER

Community distribution of Sulfadoxine-pyrimethamine (SP)

Community health workers will distribute SP to pregnant women, targeting at least three times during pregnancy.

Trial Locations (4)

Unknown

Kenge District, Community Setting, Kenge

Mananjary District, Community Setting, Mananjary

Nhamatanda District, Community Setting, Nhamatanda

Ohaukwu District, Community Setting, Ohaukwu

All Listed Sponsors
collaborator

Barcelona Institute for Global Health

OTHER

lead

Jhpiego

OTHER

NCT03998839 - TIPTOP Sulfadoxine-pyrimethamine (SP) Drug Resistance Study | Biotech Hunter | Biotech Hunter